134 related articles for article (PubMed ID: 35973004)
1. Therapeutics prior to mesenchymal stromal cell therapy improves outcome in equine orthopedic injuries.
Bernardino PN; Smith WA; Galuppo LD; Espinosa-Mur P; Cassano JM
Am J Vet Res; 2022 Aug; 83(10):. PubMed ID: 35973004
[TBL] [Abstract][Full Text] [Related]
2. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.
Lange-Consiglio A; Tassan S; Corradetti B; Meucci A; Perego R; Bizzaro D; Cremonesi F
Cytotherapy; 2013 Aug; 15(8):1011-20. PubMed ID: 23602577
[TBL] [Abstract][Full Text] [Related]
3. Clinical follow-up of horses treated with allogeneic equine mesenchymal stem cells derived from umbilical cord blood for different tendon and ligament disorders.
Van Loon VJ; Scheffer CJ; Genn HJ; Hoogendoorn AC; Greve JW
Vet Q; 2014; 34(2):92-7. PubMed ID: 25072527
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.
Ardanaz N; Vázquez FJ; Romero A; Remacha AR; Barrachina L; Sanz A; Ranera B; Vitoria A; Albareda J; Prades M; Zaragoza P; Martín-Burriel I; Rodellar C
BMC Vet Res; 2016 Mar; 12():65. PubMed ID: 27029614
[TBL] [Abstract][Full Text] [Related]
5. Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.
Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
Equine Vet J; 2020 Jul; 52(4):601-612. PubMed ID: 31821594
[TBL] [Abstract][Full Text] [Related]
6. Stem cells in veterinary medicine--attempts at regenerating equine tendon after injury.
Richardson LE; Dudhia J; Clegg PD; Smith R
Trends Biotechnol; 2007 Sep; 25(9):409-16. PubMed ID: 17692415
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic vs. autologous intra-articular mesenchymal stem cell injection within normal horses: Clinical and cytological comparisons suggest safety.
Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
Equine Vet J; 2020 Jan; 52(1):144-151. PubMed ID: 31120574
[TBL] [Abstract][Full Text] [Related]
8. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report.
Renzi S; Riccò S; Dotti S; Sesso L; Grolli S; Cornali M; Carlin S; Patruno M; Cinotti S; Ferrari M
Res Vet Sci; 2013 Aug; 95(1):272-7. PubMed ID: 23419936
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell licensing: enhancing MSC function as a translational approach for the treatment of tendon injury.
Koch DW; Schnabel LV
Am J Vet Res; 2023 Sep; 84(10):1-8. PubMed ID: 37669745
[TBL] [Abstract][Full Text] [Related]
10. Stem cells and platelet-rich plasma for the treatment of naturally occurring equine tendon and ligament injuries: a systematic review and meta-analysis.
M'Cloud WRC; Guzmán KE; Panek CL; Colbath AC
J Am Vet Med Assoc; 2024 Jun; 262(S1):S50-S60. PubMed ID: 38471305
[TBL] [Abstract][Full Text] [Related]
11. Equine allogeneic umbilical cord blood derived mesenchymal stromal cells reduce synovial fluid nucleated cell count and induce mild self-limiting inflammation when evaluated in an lipopolysaccharide induced synovitis model.
Williams LB; Koenig JB; Black B; Gibson TW; Sharif S; Koch TG
Equine Vet J; 2016 Sep; 48(5):619-25. PubMed ID: 26114736
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses.
Burk J; Wittenberg-Voges L; Schubert S; Horstmeier C; Brehm W; Geburek F
Cells; 2023 Oct; 12(21):. PubMed ID: 37947591
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses.
Carrade DD; Owens SD; Galuppo LD; Vidal MA; Ferraro GL; Librach F; Buerchler S; Friedman MS; Walker NJ; Borjesson DL
Cytotherapy; 2011 Apr; 13(4):419-30. PubMed ID: 21105841
[TBL] [Abstract][Full Text] [Related]
14. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.
Kol A; Wood JA; Carrade Holt DD; Gillette JA; Bohannon-Worsley LK; Puchalski SM; Walker NJ; Clark KC; Watson JL; Borjesson DL
Stem Cell Res Ther; 2015 Apr; 6(1):73. PubMed ID: 25888916
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells for treatment of musculoskeletal disease in horses: Relative merits of allogeneic versus autologous stem cells.
Colbath AC; Dow SW; McIlwraith CW; Goodrich LR
Equine Vet J; 2020 Sep; 52(5):654-663. PubMed ID: 31971273
[TBL] [Abstract][Full Text] [Related]
16. Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.
Sole A; Spriet M; Padgett KA; Vaughan B; Galuppo LD; Borjesson DL; Wisner ER; Vidal MA
Equine Vet J; 2013 Nov; 45(6):726-31. PubMed ID: 23574488
[TBL] [Abstract][Full Text] [Related]
17. Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model.
Joswig AJ; Mitchell A; Cummings KJ; Levine GJ; Gregory CA; Smith R; Watts AE
Stem Cell Res Ther; 2017 Feb; 8(1):42. PubMed ID: 28241885
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries?
De Schauwer C; Van de Walle GR; Van Soom A; Meyer E
Vet Q; 2013 Dec; 33(4):234-41. PubMed ID: 23697553
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):99-106. PubMed ID: 24094688
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study.
Guest DJ; Smith MR; Allen WR
Equine Vet J; 2008 Mar; 40(2):178-81. PubMed ID: 18267891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
